Zepp Health Corporation is a global smart wearables and health technology company. Among three consumer brands, their Amazfit brand accounts for over 90% of Zepp’s revenue through fitness trackers and smartwatches. Having rebranded from Huami (Xiaomi spinoff) and relocated headquarters to the Netherlands in May 2025, the company is pursuing strategic independence. Amazfit will be the focus for this pitch.

Investment Theses

ZEPP trades at approximately 1.1x trailing revenue despite clear momentum in premium wearables and a successful shift to profitability. The stock has pulled back sharply from last year’s highs near $61, but the underlying business has since only strengthened. The market appears focused on past volatility rather than current demand signals and structural progress.

Thesis #1 — Helio Strap demand is significantly stronger than the market realizes

What the market prices in

• Lingering concerns about supply constraints or potential demand slowdown after the initial launch phase.

What the market does not know

• In my personal experience and recent checks across major retailers and the official Amazfit website in multiple countries, the Helio Strap is currently sold out everywhere globally. This $99 one-time purchase alternative to WHOOP’s subscription model (ranging from $199 to $359 annually) continues to see very strong consumer pull.
• Management has already secured memory chip supply despite AI-driven price spikes, meaning the sell-outs are driven by genuine demand rather than production issues.

Thesis #2 — HYROX partnership is building a powerful, low-cost distribution flywheel

HYROX has grown from ~600 participants in 2018 to 550,000 in 2025 and is projected to exceed 1.3 million in 2026. Additionally, they are lobbying for 2032 Brisbane Olympics inclusion. As HYROX’s official Timing and Wearable Partner, Amazfit gains targeted exposure to highly engaged fitness consumers at minimal incremental cost. The Helio Strap has become a flagship product in this ecosystem which turns event growth into brand and sales momentum.

Thesis #3 — Profitability inflection is real and is ahead of expectations

Zepp achieved adjusted operating breakeven in Q3 2025 (versus an $11.3 million adjusted loss the prior year) while delivering 78.5% YoY revenue growth. Gross margins have expanded to ~38–39%, and Q4 guidance of $82–86 million (+38–45% YoY) looks achievable. This rapid one-year turnaround positions the company for further re-rating.

Valuation

Zepp trades at roughly 1.1x trailing revenue, which notably sits well below levels for reasonably growing competitors in the same space. Calculated by dividing current market cap of ~$269 million by TTM revenue of ~$233 million. A conservative 2x multiple, in line with small-cap hardware peers at this growth trajectory, points to a fair value near $28 per share (about 50% upside from here).

The main re-rating trigger is the release of Q4 2025 earnings (expected mid-March 2026), which should confirm the guided acceleration and sustained profitability path. On the bull side, the HYROX flywheel, Helio Strap demand, and breakeven inflection look underappreciated. Bears point to insider Form 144 sales near the $61 peak in October 2024 (suggesting insiders cashed out at highs), but multiple Schedule 13G filings demonstrate institutions building >5% stakes.

Catalysts and things to monitor

• Q4 2025 earnings release (expected mid-March 2026)
• Helio Strap restock timing and continued sell-out status
• HYROX event participation data and new Amazfit integrations
• Institutional ownership changes through Schedule 13G SEC filings (countering earlier insider sales)

Risks

• Competition from tech giants like Apple, Garmin, WHOOP (but highly unlikely they will move downmarket. Goes against Apple’s premium pricing strategy and Google has poor consumer hardware track record)
• Supply-chain volatility (despite mitigation)
• Consumer discretionary slowdown
• Geopolitical/tariff exposure
• Insider-selling optics (offset by institutional buying)

Conclusion

This seems to be a classic product-cycle dip where the market overreacted to short term factors while missing durable improvements. My personal observation of widespread Helio Strap sell-outs gives me high conviction that demand remains robust. Combined with the HYROX flywheel and profitability progress, ZEPP offers attractive risk/reward for the next 3-6 months.